Neurotrophic factors are known to play a crucial role in the elongation and guidance of auditory nerve ®bres to their targets within the organ of Corti. Maintenance of these neural connections following deafness would clearly in¯uence the ef®cacy of therapies for hearing recovery. The growth factors leukaemia inhibitory factor (LIF), brain-derived neurotrophic factor (BDNF) and transforming growth factor-beta 5 (TGF-â5) were tested for their ef®cacy in promoting neurite outgrowth from dissociated cultures of early postnatal rat auditory neurons. Our results indicate that while BDNF enhances neurite outgrowth in a strong fashion, LIF is more potent; moreover, the combined administration of both factors has even greater neuritogenic capacities. TGF-â5, although neurotrophic, has no neuritogenic activity on cultured auditory neurons. LIF and BDNF may therefore be potential candidates when developing pharmacological therapies for hearing recovery.
INTRODUCTION
In the auditory system, primary innervation of the auditory hair cells involves the growth of neurites from the spiral ganglion towards the developing cochlear duct, followed by the establishment of precise connections between the hair cells and spiral ganglion neurons [1] . Neurotrophic factors, in particular nerve growth factors, produced and secreted by the hair cells, are known to play a crucial role in the elongation and guidance of auditory nerve ®bres to their appropriate target within the organ of Corti [1, 2] . In particular, the neurotrophins BDNF and neurotrophin-3 (NT-3) have been identi®ed as essential for the normal development and innervation of the inner ear [1, 3] . Indeed, studies using in situ hybridization have revealed higher expression of neurotrophins on hair cells during the period when spiral ganglion cells (SGCs) send their processes to these epithelia, and at the same time spiral ganglion neurons have been found to express mRNA for the high-af®nity neurotrophin receptors trkB and trkC [4] . Further developmental studies of double mutant mice have reported that absence of both BDNF and NT-3 or of trkB and trkC leads to a nearly complete loss of inner ear neurons [3] and a complete loss of all afferent innervation of the ear [5] . These studies provide strong evidence that the neurotrophins are retrogradely transported from hair cells to the SGCs to in¯uence development and survival, and importantly, regulate synaptic connections between hair cells and SGCs for the onset of auditory function.
Neurotrophic factors have also been demonstrated to play a role in neuritogenesis and synaptic connectivity. The delivery of either BDNF or NT-3 can stimulate neurite outgrowth from early postnatal auditory neurons in dissociated cultures [6] , and also promote neuritogenesis in explant cultures of embryonic cochlear ganglia [2, 7] , suggesting a role for neurotrophins in modulating neuritic outgrowth from SGCs. Other trophic factors have also been demonstrated to induce neurite outgrowth from auditory neurons, including the cytokine ciliary-derived neurotrophic factor (CNTF). CNTF has been reported to have neuritogenic effects on organotypic explant cultures of early postnatal auditory neurons, and can also act in an additive fashion with BDNF to further enhance neurite outgrowth [7] .
Previously, we have reported that the neuronal cytokine leukaemia inhibitory factor (LIF), which is structurally homologous to CNTF, is a survival factor for auditory neurons in vitro; moreover, LIF acts synergistically with BDNF to further support the survival of cultured SGCs [8] . We have also observed that members of the transforming growth factor-beta (TGF-â) family of growth factors support the survival of cultured SGCs [9] , and in particular TGF-â5 acts in a synergistic manner with BDNF [8] .
In the present study, we have quantitatively assessed the effects of several growth factors, both individually and in combination, for their ef®cacy in promoting neurite outgrowth from early postnatal rat auditory neurons grown in vitro.
MATERIALS AND METHODS
Cultures of mammalian auditory neurons were prepared from 5-day-old Sprague±Dawley rat pups. The rat pups were anaesthetized on ice until unconscious, rapidly decapitated and the heads rinsed in 70% ethanol. Under aseptic conditions the skull was opened longitudinally, the temporal bone identi®ed and the bulla removed. In a solution of HEPES buffered Eagle's media (HEM) the cochleae was isolated, and the organ of Corti carefully removed. The modiolus of the cochleae was then digested in HEM containing 0.025% trypsin (Calbiochem) and 0.001% DNase (Boehringer Mannheim) at 378C for 30 minutes. Trypsinization was terminated by addition of 1 ml fetal calf serum (FCS), and the digested cochleae centrifuged at 1500 3 g for 10 min at room temperature. The supernatant was discarded and the tissue was then mechanically digested by trituration in a solution of HEM containing 0.001% DNase. The cell suspension was again spun at 1500 3 g for 10 min and the resultant pellet was resuspended in Dulbecco's modi®ed Eagle's medium (DMEM) with N1 supplement and 4.5 g/l glucose. The dissociated SGC suspension was pre-plated on a 35 mm tissue culture plate and incubated for 30 min at 378C with 10% CO 2 . The neuron-enriched cell suspension was collected and a cell count performed. The cells were plated at a density of 10 000 cells/well onto a 96-well tissue culture plate coated with poly-ornithine (500 ìg/ml) and laminin (0.01 mg/ml). Growth factors were added at a ®nal concentration of 50 ng/ml, since previous studies have found that BDNF, LIF and TGF-â5 have maximal survival-promoting effects when used at this concentration [8] . Cultures were maintained for 3 days at 378C with 10% CO 2 . In order to determine the initial number of neurons plated, a separate tissue culture dish was prepared and cultured for 4 h without growth factors, termed the seed plate. At the end of the appropriate culture periods the cells were ®xed in 100% ice-cold methanol and immunostained.
Immunostaining was performed using the avidin±biotin complex (ABC) method of a standard VectaStain kit (Vector). Following ®xation, the cultures were rinsed with phosphate buffered saline (PBS), and then pretreated with 2% FCS in PBS for 30 min at room temperature. The cultures were then incubated with rabbit anti-neuro®la-ment 200 kDa at 1:400 dilution for 30 min at room temperature, rinsed with 2% FCS solution and treated with the biotinylated anti-rabbit antibody (1:200 dilution) for 30 min at room temperature. The cells were then washed in PBS and reacted with ABC as per the manufacturers' instructions. Finally, cultures were reacted with diaminobenzidene (DAB; DAKO), prepared as 1 tablet in 10 ml PBS with 30 ìl hydrogen peroxide.
Surviving neurons were de®ned as those whose somas stained against the neuro®lament antibody, and with neuritic projections that were at least equal in length to three times the width of the neuronal soma. Measurements were made of neuronal length using the software package Scion image (NIH). The length of the primary axon was measured from the edge of the soma to its termination; the primary axon was identi®able as the thicker and generally more heavily stained projection. Soma size was also measured, and the number of branching points was also counted.
Neurons were measured from ®ve ®elds of view within each well, with one neuron selected within each ®eld (ie. 5 neurons/well). For those ®elds of view with more than one neuron, the neuron for measurement was selected based upon ability to follow the primary axon to its termination, as many neurons had quite convoluted projections that were dif®cult to trace. For those wells with less than 5 neurons in total, all neurons were measured, despite their location within the well. It should also be noted that it was the cell bodies of the neurons that were located within the respective ®eld of view, regardless of where the neurites extended. The ®elds of view were consistent between wells, and were such that four were located around the perimeter of the well, one each in the centre of each side and top and bottom, with the remaining ®eld of view in the centre of the well (Fig. 1) .
Data were analysed statistically using ANOVA, and Dunn's method was used for an all pairwise multiple comparison procedure. A difference was considered to be statistically signi®cant at p , 0.05.
The care and use of animals reported on in this study was approved by the Animal Research Ethics Committee of the Royal Victorian Eye and Ear Hospital, and experiments were performed in accordance with the NH&MRC of Australia.
RESULTS
SGCs were plated at a density of 1 3 10 4 cells/well, with a mean (AE s.e.m.) seed number of 497 AE 26 neurons/well. SGCs grown in culture without the addition of any growth factors (control wells) had primary axons that measured 588 AE 43 ìm. The addition of LIF to the auditory neuron cell cultures signi®cantly enhanced the elongation of the primary axons ( p , 0.05), with an average length of 1435 AE 85 ìm, a 2.4-fold increase compared with the average length of primary axons of neurons in the control wells. Treatment with BDNF also had a signi®cant effect
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Perimeter of well on the length of primary projections from SGCs ( p , 0.05), increasing the length of these projections to 925 AE 32 ìm, an $1.6-fold increase when compared to control. The addition of TGF-â5, although promoting survival, did not signi®-cantly enhance elongation of the primary axons of SGCs in culture compared with control wells ( p , 0.05), with an average length of neuronal projections of 654 AE 20 ìm (Fig.  2) .
When we co-administered LIF and BDNF extensive neuritic outgrowth was observed (Fig. 3) . In these wells we could not discern or follow the individual projections of any one neuron, nor could we measure the length of these neuronal projections. This was true for each experiment in which LIF plus BDNF was a treatment factor: a total of seven experiments, with four wells per experiment and an average of 375 AE 30 neurons/well. We also co-administered BDNF and TGF-â5; neuritic outgrowth was not signi®-cantly different from that observed with BDNF alone ( p , 0.05). The average length of the primary neuronal projection following concurrent treatment with BDNF and TGF-â5 was 883 AE 22 ìm, a 1.5-fold increase compared with controls.
Analysis of the effects of trophic factor treatment was also made for soma size and the number of branching points. None of the growth factors had a signi®cant effect on either parameter (data not shown).
DISCUSSION
We report that both LIF and BDNF promote neurite outgrowth from early postnatal auditory neurons cultured in vitro. BDNF induces a 1.6-fold increase in the average length of the primary axon when compared to control wells. In addition, we observed that LIF had a stronger neuritogenic effect than BDNF, resulting in a 2.4-fold increase in average primary axon length as compared to controls. Co-administration of these two factors led to such extensive neuritic outgrowth that it was impossible to trace individual axons of any one neuron for analysis. In contrast, TGF-â5 did not signi®cantly enhance neuritic outgrowth beyond that measured in control wells, and combined delivery of TGF-â5 with BDNF was no more effective than BDNF alone.
Several trophic factors have previously been reported to be involved in both neuritogenesis and synaptogenesis of developing and maturing neurons throughout the nervous system; however, the exact mechanisms by which they regulate or stimulate neuritogenesis remain unknown. Several possible lines of evidence may provide explanation for our current results.
First, axonal elongation depends upon the dynamics and structure of the actin cytoskeleton of the neuronal growth cone [10] . Many mechanisms have been either identi®ed or speculated as controlling factors of the neuronal cytoskeleton. One factor known to regulate actin assembly is RhoA, a member of the Ras superfamily of GTP-binding proteins [11] , which has been identi®ed to mediate growth cone collapse [12] . Recent studies have found that the common neurotrophin receptor, p75, interacts in a ligand-dependent manner with RhoA, and inactivation of Rho proteins has been reported to increase the rate of neurite elongation [13] . Therefore, BDNF signalling through the p75 receptor may alter the organization and dynamics of actin assembly and affect neurite outgrowth by regulating the activity of Rho.
Secondly, both LIF and BDNF may regulate neuritogenesis through altering calcium levels. Evidence suggests that intracellular calcium transients can govern growth cone motility and axonal growth [14] . Both LIF and the neurotrophins regulate protein kinase C (PKC) activity [15, 16] , and activation of PKC is known to mediate intracellular calcium concentrations [17] . Furthermore, BDNF has been suggested to have a close relationship with calcium-binding proteins [18] . Taken together, these ®ndings suggest that both LIF and BDNF may affect axonal outgrowth through regulation of intracellular calcium levels.
Finally, LIF and BDNF share similar intracellular effectors. Indeed, converging intracellular pathways acting downstream from LIF and BDNF have been suggested to underpin the synergy between these two growth factors when promoting survival [8] . Such convergence may also play a role in neuritic outgrowth. LIF and the neurotrophins may interact via the Ras-MAP-kinase (Ras-mitogen activated protein kinase) intracellular signalling pathway, through phosphatidyl-inositol-3 (PI-3) activation [19, 20] , or even through the STAT (signal transducers and activators of transcription) pathway, since both LIF and the neurotrophins have been indicated to regulate tyrosine phosphorylation and STAT activation [19, 21] .
We also report that TGF-â5, although neurotrophic, is not a neuritogenic factor for auditory neurons in culture. TGF-â5 alone did not enhance neuritic outgrowth signi®-cantly above that of controls, and co-administration with BDNF was no more effective than BDNF alone. Interestingly, the TGF-âs are known to regulate similar signalling pathways to LIF, namely, PKC and PI-3 turnover [22] , as well as eliciting some intracellular signalling via the Smad proteins, which in turn are reported to interact with the Ras-MAP-kinase pathway [23] . The observation that exo- genous LIF can elicit strong neuritic outgrowth from auditory neurons, while TGF-â5 does not have this capacity, suggests that perhaps the activation of the STAT signalling pathway by LIF is an important signalling pathway for neuritogenesis. In addition, LIF is also a mediator of Schwann cell survival [24] , and so may exert indirect survival effects on SGCs. These results suggest that different but overlapping mechanisms may regulate survival and neuritogenesis.
CONCLUSION
We have identi®ed LIF as a potent neuritogenic factor for auditory neurons grown in culture, and have supported previous studies identifying a similar role for BDNF. BDNF enhances neurite outgrowth in a strong fashion, however LIF is more potent, and co-administration of these two factors resulted in extensive neuritic outgrowth, past the point of analysis. In the auditory system, the maintenance of neural connections from the auditory neurons to the brain following deafness may allow for the development of pharmacological therapies for deafness. LIF and BDNF may therefore be potential candidates for such pharmacological therapy.
